  Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), linked
with CRISPR associated (CAS) genes, play a profound role in the interactions
between phage and their bacterial hosts. It is now well understood that
CRISPR-CAS systems can confer adaptive immunity against bacteriophage
infections. However, the possibility of failure of CRISPR immunity may lead to
a productive infection by the phage (cell lysis) or lysogeny. Recently,
CRISPR-CAS genes have been implicated in changes to group behaviour, including
biofilm formation, of the bacterium Pseudomonas aeruginosa when lysogenized.
For lysogens with a CRISPR system, another recent experimental study suggests
that bacteriophage re-infection of previously lysogenized bacteria may lead to
cell death. Thus CRISPR immunity can have complex effects on phage-host-lysogen
interactions, particularly in a biofilm. In this contribution, we develop and
analyse a series of models to elucidate and disentangle these interactions.
From a therapeutic standpoint, CRISPR immunity increases biofilm resistance to
phage therapy. Our models predict that lysogens may be able to displace
CRISPR-immune bacteria in a biofilm, and thus suggest strategies to eliminate
phage resistant biofilms.
